Enliven Therapeutics
ELVN
#5692
Rank
ยฃ0.86 B
Marketcap
ยฃ14.65
Share price
-5.02%
Change (1 day)
-23.54%
Change (1 year)

Enliven Therapeutics (ELVN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ11.08 Million

According to Enliven Therapeutics's latest financial reports the company's total liabilities are ยฃ11.08 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enliven Therapeutics - Total liabilities on balance sheet (from 2021 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ12.68 M-37.76%
2023-12-31ยฃ20.37 M-84.6%
2022-12-31ยฃ0.13 B14.37%
2021-12-31ยฃ0.11 B4.26%
2020-12-31ยฃ0.11 B